Literature DB >> 8918587

Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens.

J Y Wang1, U Kishore, B L Lim, P Strong, K B Reid.   

Abstract

Human lung surfactant proteins A (SP-A) and D (SP-D) are both collagenous C-type lectins which appear to mediate antimicrobial activity by binding to carbohydrates on micro-organisms and to receptors on phagocytic cells. Purified native SP-A and SP-D, isolated from human bronchoalveolar lavage fluid, were found to bind to whole mite extracts (Dermatophagoides pteronyssinus) and the purified allergen Der p I, in a carbohydrate-specific and calcium-dependent manner. Binding was inhibited by ethylenediamine tetra-acetic acid (EDTA) as well as by maltose in the case of SP-D, or mannose in the case of SP-A. A recombinant polypeptide, which trimerized to form the neck region and carbohydrate recognition domains of SP-D, also inhibited the binding of native SP-D to the whole mite extract and Der p I. Both SP-A and SP-D did not bind to deglycosylated whole mite extracts or to recombinant Der p proteins, which lacked carbohydrate residues. These results suggest that the ability of surfactant proteins to bind certain allergens is mediated through their carbohydrate-recognition domains (CRDs) interacting with carbohydrate residues on the allergens. Moreover, SP-A and SP-D were found to inhibit allergen-specific IgE binding to the mite extracts either via steric hindrance or competitive binding. It is therefore possible that SP-A and SP-D may be involved in the modulation of allergen sensitization and/or the development of allergic reactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918587      PMCID: PMC2200585          DOI: 10.1046/j.1365-2249.1996.d01-838.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

Review 1.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

Review 2.  Therapeutic use of surfactant components in allergic asthma.

Authors:  Veit J Erpenbeck; Norbert Krug; Jens M Hohlfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

3.  Epigenome-wide effects of vitamin D on asthma bronchial epithelial cells.

Authors:  Nadia Boutaoui; Sandeep Puranik; Rong Zhang; Ting Wang; Daniel H Hui; John Brehm; Erick Forno; Wei Chen; Juan C Celedón
Journal:  Epigenetics       Date:  2019-06-03       Impact factor: 4.528

Review 4.  The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.

Authors:  SeungHye Han; Rama K Mallampalli
Journal:  Ann Am Thorac Soc       Date:  2015-05

Review 5.  Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

Authors:  Katherine A Roach; Aleksandr B Stefaniak; Jenny R Roberts
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.000

6.  Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages.

Authors:  T Madan; P Eggleton; U Kishore; P Strong; S S Aggrawal; P U Sarma; K B Reid
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus.

Authors:  P Strong; K B M Reid; H Clark
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

8.  Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens.

Authors:  T Madan; U Kishore; M Singh; P Strong; H Clark; E M Hussain; K B Reid; P U Sarma
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

9.  Surfactant protein D alters allergic lung responses in mice and human subjects.

Authors:  Eric B Brandt; Melissa K Mingler; Michelle D Stevenson; Ning Wang; Gurjit K Khurana Hershey; Jeffrey A Whitsett; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2008-03-19       Impact factor: 10.793

10.  Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils.

Authors:  T Madan; U Kishore; A Shah; P Eggleton; P Strong; J Y Wang; S S Aggrawal; P U Sarma; K B Reid
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.